（1） 教育背景

2019.09-至今 博士研究生

2016.09-2019.06 内蒙古大学，硕士研究生

2011.09-2015.06 内蒙古大学，学士

（2）研究方向：肿瘤微环境响应型高分子设计与合成

（3）发表论文情况

[1] Bo Hou#, Lei Zhou#, Hui Wang, Madiha Saeed, Dangge Wang, Zhiai Xu, Yaping Li, Haijun Yu*. Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy. Adv. Mater. 2020, 1907210.

[2] Bo Hou#, Jiayi Ye#, Junhao Li, Zhiai Xu*, Haijun Yu*. In-Situ Clickable Prodrug Nanoplatform Locally Activates T Lymphocytes to Potentiate Cancer Immunotherapy. Nano today. 2022, 47, 101661.

[4] Jiayi Ye#, Bo Hou#, Madiha Saeed*, Zhiai Xu*, Haijun Yu*. Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy. Acc. Mater. Res. 2022, 3, 7, 697–708.

[5] JiayiYe#, Bo Hou#, Fangmin Chen, Shunan Zhang, Muya Xiong, Tianliang Li, Yechun Xu, Zhiai Xu, Haijun Yu*. Bispecific Prodrug Nanoparticles Circumventing Multiple Immune Resistance Mechanisms for Promoting Cancer Immunotherapy. Acta Pharm Sin B, 2021. 09. 021.

[6] Xianli Hu#, Bo Hou#, Zhiai Xu, Madiha Saeed, Fang Sun, Zhenmei Gao, Yi Lai, Tong Zhu, Fan Zhang, Wen Zhang, Haijun Yu*. Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer. Adv. Sci. 2020, 1903332.

[7] Lei Zhou#, Bo Hou#, Dangge Wang, Fang Sun, Rundi Song, Qian Shao, Hao Wang, Haijun Yu*, Yaping Li*. Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer. Nano Lett. 2020, 20, 4393−4402.

[8] Bing Feng#, Zifei Niu#, Bo Hou#, Lei Zhou, Yaping Li*, Haijun Yu*. Enhancing Triple Negative Breast Cancer Immunotherapy by ICG-Templated Self-Assembly of Paclitaxel Nanoparticles. Adv. Funct. Mater. 2019, 1906605.

[9] Bing Feng#, Bo Hou#, Zhiai Xu, Madiha Saeed, Haijun Yu*, Yaping Li*. Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy. Adv. Mater. 2019, 1902960.

[10] Jing Gao, Bo Hou, Qiwen Zhu, Lei Yang, Xingyu Jiang, Zhifeng Zou, Xutong Li, Tianfeng Xu, Mingyue Zheng, Yi-Hung Chen, Zhiai Xu*, Huixiong Xu*, Haijun Yu*. Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy. Nat Commun 2022, 13, 4318.

（4）获奖情况

1.2020年上海市药剂学年会暨青年论文报告会，二等奖，上海市级

2. 2020年第一届智能生物制造前沿交叉国际论坛暨 “中智医谷杯” 创新创业大赛，一等奖，重庆市级

3.多次荣获二等奖学金，优秀学生干部，优秀毕业论文等荣誉。